RIPK3 and Caspase-1/11 Are Necessary for Optimal Antigen-Specific CD8 T Cell Response Elicited by Genetically Modified
Casp-1/11
Effector CD8+ T cells
Listeria monocytogenes
RIPK3
ovalbumin
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
07
2019
accepted:
09
03
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
27
3
2021
Statut:
epublish
Résumé
Efficient induction of effector and long-term protective antigen-specific CD8
Identifiants
pubmed: 32328060
doi: 10.3389/fimmu.2020.00536
pmc: PMC7160319
doi:
Substances chimiques
Receptor-Interacting Protein Serine-Threonine Kinases
EC 2.7.11.1
Ripk3 protein, mouse
EC 2.7.11.1
Casp4 protein, mouse
EC 3.4.22.-
Caspases, Initiator
EC 3.4.22.-
Casp1 protein, mouse
EC 3.4.22.36
Caspase 1
EC 3.4.22.36
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
536Informations de copyright
Copyright © 2020 Rana, Campos de Almeida, Paico Montero, Gonzales Carazas, Bortoluci, Sad and Amarante-Mendes.
Références
Oncogene. 2019 May;38(19):3756-3762
pubmed: 30664692
J Immunol. 2005 Jul 1;175(1):421-32
pubmed: 15972676
Int J Infect Dis. 2018 Jul;72:1-2
pubmed: 29656135
Pathogens. 2018 Jun 16;7(2):
pubmed: 29914156
Cancer Res. 2009 May 15;69(10):4327-34
pubmed: 19435919
J Immunol. 2008 May 1;180(9):5853-61
pubmed: 18424704
Science. 2013 May 3;340(6132):635-9
pubmed: 23493421
Clin Cancer Res. 2012 Feb 1;18(3):858-68
pubmed: 22147941
Mol Cell Biol. 2004 Feb;24(4):1464-9
pubmed: 14749364
Immunity. 2007 Jun;26(6):827-41
pubmed: 17555991
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
J Immunol. 2016 Mar 15;196(6):2838-46
pubmed: 26864034
Nat Immunol. 2001 May;2(5):415-22
pubmed: 11323695
Int J Gynecol Cancer. 2018 May;28(4):764-772
pubmed: 29538258
J Clin Oncol. 2015 Apr 20;33(12):1325-33
pubmed: 25584002
Science. 2007 Oct 5;318(5847):116-20
pubmed: 17916739
J Cell Biol. 2019 Jun 3;218(6):1994-2005
pubmed: 30975711
Immunol Rev. 1997 Aug;158:129-36
pubmed: 9314081
Int Immunol. 2004 Feb;16(2):335-43
pubmed: 14734619
Hum Vaccin Immunother. 2016 Apr 2;12(4):1085-6
pubmed: 26618528
Front Cell Infect Microbiol. 2017 Jun 29;7:279
pubmed: 28706878
Eur J Immunol. 2011 Jul;41(7):1934-40
pubmed: 21538346
J Immunol. 2002 Feb 15;168(4):1528-32
pubmed: 11823476
Ther Adv Vaccines. 2014 May;2(3):77-89
pubmed: 24790732
J Cell Physiol. 2019 Jun;234(6):8509-8521
pubmed: 30520029
Microbiol Spectr. 2019 Mar;7(2):
pubmed: 30848231
Front Immunol. 2017 Sep 20;8:1152
pubmed: 28979262
Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1175-1178
pubmed: 29722659
Cell Death Differ. 2017 Nov;24(11):1900-1911
pubmed: 28686578
Nat Rev Microbiol. 2006 Jun;4(6):423-34
pubmed: 16710323
Infect Immun. 2000 Jun;68(6):3680-8
pubmed: 10816528
J Immunol. 2002 Jun 1;168(11):5737-45
pubmed: 12023374
J Immunol. 2016 Jan 1;196(1):274-83
pubmed: 26597009
Immunity. 1998 Mar;8(3):353-62
pubmed: 9529152
J Immunol. 2016 Dec 15;197(12):4593-4602
pubmed: 27849166
Methods. 2013 Jun 1;61(2):105-9
pubmed: 23454288
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
Infect Immun. 2006 Mar;74(3):1528-36
pubmed: 16495523
FEMS Immunol Med Microbiol. 2000 Apr;27(4):341-9
pubmed: 10727890
J Immunol. 2015 Oct 1;195(7):3206-17
pubmed: 26311905
Vaccines (Basel). 2018 Jul 25;6(3):
pubmed: 30044426
Br J Cancer. 2013 Jun 11;108(11):2281-90
pubmed: 23640395